Compare Us Fda

Rediff.com » News » Compare Us Fda

News for Compare Us Fda

News
Business
Sports

Eye disease drug may stop reproduction of coronavirus, says study

A drug already approved in the US for eye disease may stop the reproduction of SARS-CoV-2, the virus that causes COVID-19, according to a study. Image used for representational purpose only.......

216 cr vaccine doses to be available between Aug-Dec: Centre

As states grapple with a shortage of coronavirus vaccines, the Centre on Thursday said that over two billion doses will be made available in the country in five months between August and December,......

'Why did the government delay the vaccine?'

'The government had a vaccine from January.''The government should have given the vaccine to all population above the age of 45, right from the start.''Each state has its own problems, but as far......

US approves Johnson & Johnson's Covid vaccine

The United States Food and Drug Administration has approved Johnson and Johnson's COVID-19 vaccine that works with just one dose instead of two for emergency use, giving America its third jab to......

COVID-19 vaccine unlikely before Fall of 2021: Experts

An effective vaccine is not likely to be available for the general public before the fall of 2021, according to experts working in the field of vaccine development. Researchers at McGill......

iPhone 16 with AI steals show as Apple unveils new Airpods and watch

In a dazzling showcase at Apple Park, Cupertino, California, Apple on Monday introduced its latest technological marvels, including the much-anticipated iPhone 16 lineup. The event, held at the......

Why analysts have turned cautious on Cipla

Analysts have turned cautious on Cipla, as the recently issued form 483 by the US FDA with eight observations to its Pithampur (Indore) plant is expected to delay the launch of the company’s......

Company Watch: Emami, Shriram Transport, Lupin

Check out some of the stocks that will react on the basis of their numbers in the near term. Photograph: Kind courtesy Gerd Altmann/Pixabay Emami: More gains ahead for the stock? Yash......

3 sectors to watch for as economic growth picks up

Prudence in capital and development expenditure, efficient working-capital management, and recent equity raising will help sustain credit metrics in FY22, says Subodh Rai. Telcos will push to raise......

Why investors are regretting giving Gland Pharma IPO a miss

Gland Pharma, promoted by China's Fosun, has extended its gains, is up 40 per cent since its listing. Illustration: Uttam Ghosh/Rediff.com Retail and high-networth individuals (HNIs) would be......

Alonso apologises to 'legend' Hamilton after Spa spat

IMAGE: Alpine's Fernando Alonso arrives ahead of the Dutch Grand Prix. Photograph: Piroschka Van De Wouw/Reuters Fernando Alonso apologised on Thursday for calling Lewis Hamilton an idiot......

Sharapova's intent questioned - Why was she taking banned heart drug?

'Sharapova has been a US resident since early in her career, which does bring in a question of how or why she is using a drug that is not licensed there' IMAGE: Maria Sharapova speaks to the media......

Rediff News